Hennepin Healthcare Research Institute

hhrinstitute.org

Total trials

72

Active

8

Phase 3

0

Total enrollment

65,275

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 5 of 5 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Conjugate Pneumococcal Vaccine 201
Nicotine Patch, 14 Mg/24 Hr Transdermal Film, Extended Release1
Nicotine lozenge1
magnesium sulfate1
Normal Saline1

Next readouts

  • 2025-05-28
  • 2026-12-01
  • 2028-09-15

Top conditions

  • Acute Coronary Syndrome7
  • Diabetes Mellitus4
  • Acute Myocardial Infarction4
  • Agitation3
  • Sedation3
  • Inflammation3
  • HIV Infection3
  • Acute Respiratory Failure3

Frequently asked questions about Hennepin Healthcare Research Institute

How many clinical trials does Hennepin Healthcare Research Institute have on ClinicalTrials.gov?
Hennepin Healthcare Research Institute is listed as the lead sponsor on 72 clinical trials in ClinicalTrials.gov, 8 of which are currently active (recruiting, enrolling, or ongoing).
How many of Hennepin Healthcare Research Institute's trials are in Phase 3?
0 of Hennepin Healthcare Research Institute's trials are in Phase 3, spread across 5 active drug programs.
What therapeutic areas does Hennepin Healthcare Research Institute focus on?
Hennepin Healthcare Research Institute's most-studied conditions on ClinicalTrials.gov are Acute Coronary Syndrome, Diabetes Mellitus, Acute Myocardial Infarction, Agitation, Sedation.
When are Hennepin Healthcare Research Institute's next clinical trial readouts?
Hennepin Healthcare Research Institute has 3 upcoming primary-completion readouts tracked here; the soonest is “Free Samples for Health”, expected around 2025-05-28.